Similar articles for PMID: 21728021

Year	Number of Results
1985	1
1987	1
1988	6
1989	3
1990	4
1991	2
1992	3
1993	4
1995	1
1996	3
1997	2
1998	1
1999	1
2000	1
2001	1
2002	1
2003	1
2008	2
2009	4
2010	4
2011	12
2012	6
2013	4
2014	3
2015	5
2016	6
2017	6
2018	7
2019	7
2020	1
2022	1
2024	0

1

First case of posterior reversible encephalopathy syndrome associated with vinflunine.

Helissey C, Chargari C, Lahutte M, Ricard D, Vedrine L, Ceccaldi B, Le Moulec S. Helissey C, et al. Invest New Drugs. 2012 Oct;30(5):2032-4. doi: 10.1007/s10637-011-9712-7. Epub 2011 Jul 5. Invest New Drugs. 2012. PMID: 21728021 No abstract available.

2

[Activity and efficacy of vinflunine in metastatic carcinoma of the bladder after failure of adjuvant treatment: description of a clinical case].

Morelli F. Morelli F. Recenti Prog Med. 2015 Jun;106(6):e300-5. doi: 10.1701/1884.20570. Recenti Prog Med. 2015. PMID: 26076423 Italian.

3

Vinflunine in Advanced Transitional Cell Cancer of the Urothelial Tract: A Potential Option for Maintenance Therapy? A Case Series.

Palumbo R, Licata L, Sottotetti F, Tagliaferri B, Pozzi E, Teragni C, Quaquarini E, Bernardo A. Palumbo R, et al. Oncol Res Treat. 2018;41(1-2):8-13. doi: 10.1159/000481098. Epub 2018 Jan 22. Oncol Res Treat. 2018. PMID: 29402855

4

Vinflunine.

[No authors listed] [No authors listed] Prescrire Int. 2011 Jan;20(112):11-3. Prescrire Int. 2011. PMID: 21462785 Review.

5

Vinblastine-induced posterior reversible encephalopathy syndrome.

Ayesh Haj Yousef MH, Eyadeh A, Rawashdeh RA, Khasawneh R, Saleh JA, Jibreel MJ. Ayesh Haj Yousef MH, et al. J Oncol Pharm Pract. 2019 Dec;25(8):2019-2022. doi: 10.1177/1078155218816776. Epub 2018 Dec 11. J Oncol Pharm Pract. 2019. PMID: 30537916

6

Effectiveness, toxicity, and economic evaluation of vinflunine for the treatment of patients with transitional cell carcinoma in the Spanish outpatient setting.

Guglieri-López B, Pérez-Pitarch A, Porta-Oltra B, Ferriols-Lisart F, Climente-Martí M, Alós-Almiñana M. Guglieri-López B, et al. Anticancer Drugs. 2015 Sep;26(8):860-5. doi: 10.1097/CAD.0000000000000240. Anticancer Drugs. 2015. PMID: 25919319

7

Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy.

Bellmunt J, Fougeray R, Rosenberg JE, von der Maase H, Schutz FA, Salhi Y, Culine S, Choueiri TK. Bellmunt J, et al. Ann Oncol. 2013 Jun;24(6):1466-72. doi: 10.1093/annonc/mdt007. Epub 2013 Feb 17. Ann Oncol. 2013. PMID: 23419284 Free article. Clinical Trial.

8

Vinflunine.

Frampton JE, Moen MD. Frampton JE, et al. Drugs. 2010 Jul 9;70(10):1283-93. doi: 10.2165/11204970-000000000-00000. Drugs. 2010. PMID: 20568834 Review.

9

Clinical activity of vinflunine in transitional cell carcinoma of the urothelium and other solid tumors.

Bellmunt J, Delgado FM, George C. Bellmunt J, et al. Semin Oncol. 2008 Jun;35(3 Suppl 3):S34-43. doi: 10.1053/j.seminoncol.2008.01.008. Semin Oncol. 2008. PMID: 18538178 Review.

10

Long-term response in advanced bladder cancer involving the use of temsirolimus and vinflunine after platin resistance.

Gerullis H, Ecke TH, Janusch B, Arndt C, Heidari M, Oniani J, Otto T. Gerullis H, et al. Anticancer Drugs. 2011 Oct;22(9):940-3. doi: 10.1097/CAD.0b013e328347a86a. Anticancer Drugs. 2011. PMID: 21642839

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

92 results

Results by year